Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study

Background: In spite of laser being the gold standard treatment for Diabetic Macular edema (DME), some patients do not respond to laser. Various treatment modalities are being tried in the management of refractory diffuse DME (DDME). Purpose: To compare the efficacy of intravitreal bevacizumab (IVB...

Full description

Bibliographic Details
Main Authors: Rajvardhan Azad, Siddarth Sain, Yog Raj Sharma, Deepankur Mahajan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Oman Journal of Ophthalmology
Subjects:
Diabetic macular edema
Intravitreal bevacizumab
Intravitreal triamcinolone
laser photocoagulation
Online Access:http://www.ojoonline.org/article.asp?issn=0974-620X;year=2012;volume=5;issue=3;spage=166;epage=170;aulast=Azad

Internet

http://www.ojoonline.org/article.asp?issn=0974-620X;year=2012;volume=5;issue=3;spage=166;epage=170;aulast=Azad

Similar Items